2022 Program Day 1

Dr. Khalid Saeed Balaraj

Chair of Oncology Service | United Arab Emirates

Dr. Khalid Balaraj was initially trained in the United Kingdom. He has radiation oncology qualifications from - UK (FRCR (I), Ireland (FFR RCSI) and Canada (FRCPC). He has done 2 Clinical Fellowships from Canada, in Gynecology Brachytherapy and CNS Stereotactic Radiotherapy. He has worked as an Assistant Professor in Al Faisal University, Riyadh, as well as Consultant of Radiation Oncology, for 7 years, treating patients on the latest technology, including IMRT, IGRT, Tomotherapy, Rapid Arc and Cyber- Knife at King Faisal specialist Hospital, Riyadh. Dr. Balaraj has treated patients on international RTOG trials. He has been General Secretary of the Saudi Cancer Society and Oncology Advisor for the CME Oncology Program Middle East. Joined Tawam hospital as a chairman of Radiation oncology department on September 2011 Currently he is an assistant professor at UAE University and the chairman of Tawam hospital Oncology Services and the chair of oncology service line at SEHA.

Prof. Syed Hussain

Professor and Consultant in Medical Oncology | United Kingdom

"Professor Hussain graduated from Dow Medical College Karachi in 1994. He completed his general medical professional training in UK. He did his Doctorate in Oncology from University of Birmingham. He then completed his Medical oncology training in Birmingham, United Kingdom and received his certification and specialist registration in Medical oncology. Professor Hussain is Professor and Consultant in Medical Oncology at the University of Sheffield and Sheffield Teaching Hospitals NHS Trust. His major areas of interest are management of urological cancers, clinical trials, early drug development and translational medicine. He has set up large number of clinical trials from early phase to late phase studies during his career. His work on organ preservation in bladder cancer moved all the way from an early phase I study (Hussain et al Annals of Oncology 2001) to phase II efficacy study (Hussain et al BJC 2004) that led to a Cancer Research UK funded study BC2001 trial that was reported in New England Journal of Medicine (James, Hussain, Hall et al April 2012). This study has now changed the standard of care for patients with muscle invasive bladder cancer opting for organ preservation treatment. Professor Hussain is principal investigator of number of studies in urological cancers. He is a chief investigator of a national randomised placebo-controlled phase II neo-adjuvant study in muscle invasive bladder cancer. He served as chief investigator of various early phase trials, and translational studies. Professor Hussain has authored over 105 peer-reviewed publications including 4 book chapters in textbooks of oncology. His Google scholar H-index is 37 with over 8300 citations. He has published in high impact journals including New England Journal of medicine, Lancet, Lancet Oncology, JAMA, JAMA Oncology, Journal of Clinical oncology, European Urology, Annals of Oncology, Nature communications, Clinical Cancer Research, British journal of Cancer. He has been an invited speaker to number of national and international meetings. Professor Hussain has secured funding of over 10 million pounds from funding bodies. "

Prof. Daniel Palmer

Professor and Honorary Consultant in Medical Oncology | United Kingdom

Professor Palmer took his current position of North West Cancer Research Chair in Medical Oncology at the University of Liverpool in 2011. His research interests relate to HPB cancers (liver, pancreas and biliary tract) and incorporate basic laboratory science, translational research and clinical trials. His laboratory research is currently investigating novel therapeutic approaches to the treatment of HPB cancer through stimulation of anti-tumour immune responses and targeting tumour micro-environment including the tumour microbiome, and developing and validating biomarkers for a stratified approach to treatment. He is a member of the UK NCRN Upper GI cancers clinical studies group, and the hepatobiliary and pancreatic sub-groups. He is Director of the Cancer Research UK/NIHR Liverpool Experimental Cancer Medicine Centre and has established a portfolio of early phase clinical trials and translational studies and he is Chief Investigator for the TACE-3 and RaTIO trials investigating immunotherapy combinations for patients with intermediate and advanced HCC respectively.

Dr. Vivek Muthu

Managing Director | United Kingdom

A company founder experienced in health systems, life sciences and business leadership and management, Dr Vivek Muthu originally worked as a physician in the UK, including at London's Queen Square, the Hammersmith and Oxford University hospitals. He then joined the British Medical Journal, where he helped to develop and lead a team examining the clinical evidence on safety and efficacy of drugs and devices. During that time he also co-authored a popular handbook for junior doctors. He went on to found Bazian, a company dedicated to developing and servicing the needs of the emerging paradigm of value-based health internationally, focusing on the application of research, data and evidence on ensuring that health services and technologies deliver high quality, safe, cost-effective care. Having sold and integrated Bazian into the Economist Group to create its healthcare practice, Vivek took executive leadership and strategic responsibility for the business globally and continues to consult for the business. He additionally holds non-executive and advisory roles in healthcare companies in the health policy, biotech and data spaces and is additionally involved in international initiatives in health systems improvement and sustainability. Areas of focus include access and adoption of novel and sophisticated biotechnologies, principally in oncology, in an increasingly challenging healthcare and payer environment dominated by concerns around budget impact, population health value and financial sustainability.

Dr. Vivek Muthu

Managing Director | United Kingdom

A company founder experienced in health systems, life sciences and business leadership and management, Dr Vivek Muthu originally worked as a physician in the UK, including at London's Queen Square, the Hammersmith and Oxford University hospitals. He then joined the British Medical Journal, where he helped to develop and lead a team examining the clinical evidence on safety and efficacy of drugs and devices. During that time he also co-authored a popular handbook for junior doctors. He went on to found Bazian, a company dedicated to developing and servicing the needs of the emerging paradigm of value-based health internationally, focusing on the application of research, data and evidence on ensuring that health services and technologies deliver high quality, safe, cost-effective care. Having sold and integrated Bazian into the Economist Group to create its healthcare practice, Vivek took executive leadership and strategic responsibility for the business globally and continues to consult for the business. He additionally holds non-executive and advisory roles in healthcare companies in the health policy, biotech and data spaces and is additionally involved in international initiatives in health systems improvement and sustainability. Areas of focus include access and adoption of novel and sophisticated biotechnologies, principally in oncology, in an increasingly challenging healthcare and payer environment dominated by concerns around budget impact, population health value and financial sustainability.

Prof. Daniel Palmer

Professor and Honorary Consultant in Medical Oncology | United Kingdom

Professor Palmer took his current position of North West Cancer Research Chair in Medical Oncology at the University of Liverpool in 2011. His research interests relate to HPB cancers (liver, pancreas and biliary tract) and incorporate basic laboratory science, translational research and clinical trials. His laboratory research is currently investigating novel therapeutic approaches to the treatment of HPB cancer through stimulation of anti-tumour immune responses and targeting tumour micro-environment including the tumour microbiome, and developing and validating biomarkers for a stratified approach to treatment. He is a member of the UK NCRN Upper GI cancers clinical studies group, and the hepatobiliary and pancreatic sub-groups. He is Director of the Cancer Research UK/NIHR Liverpool Experimental Cancer Medicine Centre and has established a portfolio of early phase clinical trials and translational studies and he is Chief Investigator for the TACE-3 and RaTIO trials investigating immunotherapy combinations for patients with intermediate and advanced HCC respectively.

Prof. Syed Hussain

Professor and Consultant in Medical Oncology | United Kingdom

"Professor Hussain graduated from Dow Medical College Karachi in 1994. He completed his general medical professional training in UK. He did his Doctorate in Oncology from University of Birmingham. He then completed his Medical oncology training in Birmingham, United Kingdom and received his certification and specialist registration in Medical oncology. Professor Hussain is Professor and Consultant in Medical Oncology at the University of Sheffield and Sheffield Teaching Hospitals NHS Trust. His major areas of interest are management of urological cancers, clinical trials, early drug development and translational medicine. He has set up large number of clinical trials from early phase to late phase studies during his career. His work on organ preservation in bladder cancer moved all the way from an early phase I study (Hussain et al Annals of Oncology 2001) to phase II efficacy study (Hussain et al BJC 2004) that led to a Cancer Research UK funded study BC2001 trial that was reported in New England Journal of Medicine (James, Hussain, Hall et al April 2012). This study has now changed the standard of care for patients with muscle invasive bladder cancer opting for organ preservation treatment. Professor Hussain is principal investigator of number of studies in urological cancers. He is a chief investigator of a national randomised placebo-controlled phase II neo-adjuvant study in muscle invasive bladder cancer. He served as chief investigator of various early phase trials, and translational studies. Professor Hussain has authored over 105 peer-reviewed publications including 4 book chapters in textbooks of oncology. His Google scholar H-index is 37 with over 8300 citations. He has published in high impact journals including New England Journal of medicine, Lancet, Lancet Oncology, JAMA, JAMA Oncology, Journal of Clinical oncology, European Urology, Annals of Oncology, Nature communications, Clinical Cancer Research, British journal of Cancer. He has been an invited speaker to number of national and international meetings. Professor Hussain has secured funding of over 10 million pounds from funding bodies. "

Dr. Khalid Saeed Balaraj

Chair of Oncology Service | United Arab Emirates

Dr. Khalid Balaraj was initially trained in the United Kingdom. He has radiation oncology qualifications from - UK (FRCR (I), Ireland (FFR RCSI) and Canada (FRCPC). He has done 2 Clinical Fellowships from Canada, in Gynecology Brachytherapy and CNS Stereotactic Radiotherapy. He has worked as an Assistant Professor in Al Faisal University, Riyadh, as well as Consultant of Radiation Oncology, for 7 years, treating patients on the latest technology, including IMRT, IGRT, Tomotherapy, Rapid Arc and Cyber- Knife at King Faisal specialist Hospital, Riyadh. Dr. Balaraj has treated patients on international RTOG trials. He has been General Secretary of the Saudi Cancer Society and Oncology Advisor for the CME Oncology Program Middle East. Joined Tawam hospital as a chairman of Radiation oncology department on September 2011 Currently he is an assistant professor at UAE University and the chairman of Tawam hospital Oncology Services and the chair of oncology service line at SEHA.

Dr. Jawaher Ali Ansari

Acting Chief, Oncology Clinic | United Arab Emirates

Dr Jawaher Ansari completed his Clinical Oncology specialist training in Birmingham, UK and worked as a Consultant at the Beatson Cancer Centre in Glasgow, the second largest cancer center in the UK, prior to moving to the Middle East. Dr Ansari has been a principal investigator for several international clinical trials and has authored several peer-reviewed publications and textbook chapters. He has a specialist interest in Urology, Breast and Lung cancers.

Mr. Mahmoud Abdul Rahim Hasan

Assistant Director of Nursing | United Arab Emirates

Mahmoud is the Assistant Director of Nursing for Oncology, Medical, Surgical, Al Wagan Hospital, and Regional Blood Bank at Tawam Hospital (UAE). He graduated from the Makkassed National College of Nursing, Lebanon in 2001 with a Bachelor of Sciences in Nursing and he completed his Master degree in Healthcare Management from the Royal College of Surgeons in Ireland in Dubai (RCSI-Dubai) in June 2010. He is an Oncology Certified Nurse by the Oncology Nursing Society (ONS, USA). Mahmoud chaired all the annual nursing sessions in the Emirates Oncology Conference from 2013 till today. He participated in a lot of activities to improve patient quality of care such as introducing the new appointment system in the oncology Clinic at Tawam Hospital (2010), introducing the new Medical Assessment & Planning Unit (MAPU) in 2017, End of life Outreach Nurse project (2017), Discharge project (2017-2018), Oncology Nurse Navigator program (2017) and Oncology Nurse Triage project (2018). He also work with oncology nursing team at Tawam hospital to conduct number of oncology nursing researches such as improving oral chemotherapy compliance in Oncology Clinic (2017), improving patient experience with Chemotherapy-induced nausea and vomiting (CINV), Tawam Experience (2017) and Assessing the Patient Education needs of Thalassemia Patients taking Iron chelating factors, Experience of Tawam hospital adult hematology/oncology department in the UAE (2018).

Mr. Khaled Al Qawasmeh

Clinical Research Nurse | United Arab Emirates

Khaled Al Qawasmeh qualified with Master’s Degree in Clinical Oncology Nursing from the University of Pennsylvania, Philadelphia, USA. He is an Oncology Certified Nurse (OCN) since 2009. Khaled has gained the prestigious Clinical Research Certification by SOCRA USA. Khaled is currently the president of the Emirates Oncology/Hematology Nursing Society.

Mr. Mohammad Mah'D Saleh

Oncology Center Manager | United Arab Emirates

Mr. Saleh is an Oncology Certified Nurse OCN with extensive clinical experience in oncology/hematology. After vast years of experience in nursing from a clinical educator, Nurse Manager and now being the Tawam Oncology Center Manager. He participates effectively in training and developing nursing staff. Mohammad has served as a Chemotherapy and Biotherapy Trainer since 2011 and was the first international trainer at the level of UAE. He was responsible for a variety of quality improvement initiatives and hospital quality measures such as central line associated blood stream infections (CLABSI), prevention of chemotherapy error, and improving the safe handling of hazardous drugs, and management of radiation therapy side effects based in the latest evidence based practice. Mohammad, actively participates in oncology service development and collaborate with others in setting the standards in cancer care and improve quality and cancer patient’s outcome through continuum of care, and customer services and be connected with local and international cancer centers.

Mr. Khalid Al Habaybia

Nurse Manager, Paediatric Haematology-Oncology Unit | United Arab Emirates

Khalid is currently a Acting Nurse Manager within the Paediatric Haematology-Oncology Unit at the Tawam Hospital, United Arab Emirates. Prior to this, Khalid graduated from the Faculty of Nursing at the University of Jordan in Amman, Jordan before going on to obtain a Master’s of Science in Healthcare Administration at the University of Atlanta in the USA. He actively participates in many haemophilia-focussed groups, taking on the role of Nurses Committee Member for the World Federation of Haemophilia (WFH), and General Secretary and Haemophilia Nurse at the United Arab Emirates Haemophilia Group, recently chosen as WFH World Congress Ambassador 2020. Khalid is also the Chairperson for the Nursing Care Working Group initiated by the Paediatric Oncology Eastern Mediterranean (POEM) Group, which aims to continuously improve paediatric oncology care, research, training and advocacy in the eastern and Mediterranean region by means of integrated teamwork.

Ms. Kanaga Murugan

Oncology Clinical Educator | United Arab Emirates

"Kanaga Murugan is working as Clinical Nurse Educator for Adult Oncology Division in Tawam Hospital with an overall experience of 22 ys both in Clinical as well as Teaching. She received her Master’s degree in Hospital Administration 2017 from Jaipur University, India. She joined Tawam in March 2009 as a RN in Oncology unit. She has extensive experience and skills with various divisions within oncological care. She did Research in Oncology unit about assessing fatigue and activity intolerance in patients with cancer receiving treatment. She was a conference speaker at the 6th SEHA international Nursing, Midwifery and Allied health conference last September 2017 Abu Dhabi. She presented in EIOC in 2019 , 9th EOC in 2021. She is also a committee member of the Nursing Midwifery education & Research Unit (NMERU) at Tawam Hospital and is completing a Quality Improvement Project aimed at standardizing central line care and management. Currently she is the Lead of Oncology Educational Nursing advisory Group. "

Mr. Khaled Al Qawasmeh

Clinical Research Nurse | United Arab Emirates

Khaled Al Qawasmeh qualified with Master’s Degree in Clinical Oncology Nursing from the University of Pennsylvania, Philadelphia, USA. He is an Oncology Certified Nurse (OCN) since 2009. Khaled has gained the prestigious Clinical Research Certification by SOCRA USA. Khaled is currently the president of the Emirates Oncology/Hematology Nursing Society.

Mr. Mahmoud Abdul Rahim Hasan

Assistant Director of Nursing | United Arab Emirates

Mahmoud is the Assistant Director of Nursing for Oncology, Medical, Surgical, Al Wagan Hospital, and Regional Blood Bank at Tawam Hospital (UAE). He graduated from the Makkassed National College of Nursing, Lebanon in 2001 with a Bachelor of Sciences in Nursing and he completed his Master degree in Healthcare Management from the Royal College of Surgeons in Ireland in Dubai (RCSI-Dubai) in June 2010. He is an Oncology Certified Nurse by the Oncology Nursing Society (ONS, USA). Mahmoud chaired all the annual nursing sessions in the Emirates Oncology Conference from 2013 till today. He participated in a lot of activities to improve patient quality of care such as introducing the new appointment system in the oncology Clinic at Tawam Hospital (2010), introducing the new Medical Assessment & Planning Unit (MAPU) in 2017, End of life Outreach Nurse project (2017), Discharge project (2017-2018), Oncology Nurse Navigator program (2017) and Oncology Nurse Triage project (2018). He also work with oncology nursing team at Tawam hospital to conduct number of oncology nursing researches such as improving oral chemotherapy compliance in Oncology Clinic (2017), improving patient experience with Chemotherapy-induced nausea and vomiting (CINV), Tawam Experience (2017) and Assessing the Patient Education needs of Thalassemia Patients taking Iron chelating factors, Experience of Tawam hospital adult hematology/oncology department in the UAE (2018).

Mr. Mohammad Mah'D Saleh

Oncology Center Manager | United Arab Emirates

Mr. Saleh is an Oncology Certified Nurse OCN with extensive clinical experience in oncology/hematology. After vast years of experience in nursing from a clinical educator, Nurse Manager and now being the Tawam Oncology Center Manager. He participates effectively in training and developing nursing staff. Mohammad has served as a Chemotherapy and Biotherapy Trainer since 2011 and was the first international trainer at the level of UAE. He was responsible for a variety of quality improvement initiatives and hospital quality measures such as central line associated blood stream infections (CLABSI), prevention of chemotherapy error, and improving the safe handling of hazardous drugs, and management of radiation therapy side effects based in the latest evidence based practice. Mohammad, actively participates in oncology service development and collaborate with others in setting the standards in cancer care and improve quality and cancer patient’s outcome through continuum of care, and customer services and be connected with local and international cancer centers.

Dr. Mikaela Olsen

Clinical Program Director for Oncology | USA

"MiKaela M. Olsen, DNP, APRN-CNS, AOCNS®, FAAN, is the Clinical Program Director for Oncology at the Johns Hopkins Hospital and the Johns Hopkins Health System. Dr. Olsen serves as adjunct faculty for the Johns Hopkins School of Nursing and has a joint faculty appointment with the Johns Hopkins University. She is also a faculty Associate at the University Of Maryland School Of Nursing. Dr. Olsen received her Bachelor of Science in Nursing from Texas Christian University in Fort Worth Texas in 1989 and a Master of Science degree with special emphasis in Oncology nursing from the University of California at San Francisco in 1996. She graduated with her Doctor of Nursing Practice degree from University of Maryland in 2019. She is a certified Advanced Oncology Clinical Nurse Specialist. Dr. Olsen is co-editor of the ONS Safe Handling of Hazardous Drugs Guidelines (2018). She is currently the lead editor for the 1st edition of the Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (2019). She served on the American Society of Clinical Oncology (ASCO) and ONS Chemotherapy Safety Standards Workgroup (2016). She is the lead editor of the book “Hematologic Malignancies in Adults”, the first nursing textbook published to guide nurses in the care of hematologic malignancy patients. Dr. Olsen has published and extensively presented on the topic of safe handling of hazardous drugs. Working closely with the Institute for Safe Medication Practices (ISMP) as an expert advisory panelist, she has written recommendations for safe administration of chemotherapy and adult intravenous push medications. To increase nurses knowledge of the potential serious health risks associated with HD exposure, she assisted in the development of ONS continuing education (CE) courses. As an instructor and consultant, Dr. Olsen has traveled to countries including Singapore, UAE, China, Bulgaria, and Japan to increase awareness of HD exposure risks and safe handling. "

Dr. Mikaela Olsen

Clinical Program Director for Oncology | USA

"MiKaela M. Olsen, DNP, APRN-CNS, AOCNS®, FAAN, is the Clinical Program Director for Oncology at the Johns Hopkins Hospital and the Johns Hopkins Health System. Dr. Olsen serves as adjunct faculty for the Johns Hopkins School of Nursing and has a joint faculty appointment with the Johns Hopkins University. She is also a faculty Associate at the University Of Maryland School Of Nursing. Dr. Olsen received her Bachelor of Science in Nursing from Texas Christian University in Fort Worth Texas in 1989 and a Master of Science degree with special emphasis in Oncology nursing from the University of California at San Francisco in 1996. She graduated with her Doctor of Nursing Practice degree from University of Maryland in 2019. She is a certified Advanced Oncology Clinical Nurse Specialist. Dr. Olsen is co-editor of the ONS Safe Handling of Hazardous Drugs Guidelines (2018). She is currently the lead editor for the 1st edition of the Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (2019). She served on the American Society of Clinical Oncology (ASCO) and ONS Chemotherapy Safety Standards Workgroup (2016). She is the lead editor of the book “Hematologic Malignancies in Adults”, the first nursing textbook published to guide nurses in the care of hematologic malignancy patients. Dr. Olsen has published and extensively presented on the topic of safe handling of hazardous drugs. Working closely with the Institute for Safe Medication Practices (ISMP) as an expert advisory panelist, she has written recommendations for safe administration of chemotherapy and adult intravenous push medications. To increase nurses knowledge of the potential serious health risks associated with HD exposure, she assisted in the development of ONS continuing education (CE) courses. As an instructor and consultant, Dr. Olsen has traveled to countries including Singapore, UAE, China, Bulgaria, and Japan to increase awareness of HD exposure risks and safe handling. "

Dr. Mikaela Olsen

Clinical Program Director for Oncology | USA

"MiKaela M. Olsen, DNP, APRN-CNS, AOCNS®, FAAN, is the Clinical Program Director for Oncology at the Johns Hopkins Hospital and the Johns Hopkins Health System. Dr. Olsen serves as adjunct faculty for the Johns Hopkins School of Nursing and has a joint faculty appointment with the Johns Hopkins University. She is also a faculty Associate at the University Of Maryland School Of Nursing. Dr. Olsen received her Bachelor of Science in Nursing from Texas Christian University in Fort Worth Texas in 1989 and a Master of Science degree with special emphasis in Oncology nursing from the University of California at San Francisco in 1996. She graduated with her Doctor of Nursing Practice degree from University of Maryland in 2019. She is a certified Advanced Oncology Clinical Nurse Specialist. Dr. Olsen is co-editor of the ONS Safe Handling of Hazardous Drugs Guidelines (2018). She is currently the lead editor for the 1st edition of the Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (2019). She served on the American Society of Clinical Oncology (ASCO) and ONS Chemotherapy Safety Standards Workgroup (2016). She is the lead editor of the book “Hematologic Malignancies in Adults”, the first nursing textbook published to guide nurses in the care of hematologic malignancy patients. Dr. Olsen has published and extensively presented on the topic of safe handling of hazardous drugs. Working closely with the Institute for Safe Medication Practices (ISMP) as an expert advisory panelist, she has written recommendations for safe administration of chemotherapy and adult intravenous push medications. To increase nurses knowledge of the potential serious health risks associated with HD exposure, she assisted in the development of ONS continuing education (CE) courses. As an instructor and consultant, Dr. Olsen has traveled to countries including Singapore, UAE, China, Bulgaria, and Japan to increase awareness of HD exposure risks and safe handling. "

Ms. Kanaga Murugan

Oncology Clinical Educator | United Arab Emirates

"Kanaga Murugan is working as Clinical Nurse Educator for Adult Oncology Division in Tawam Hospital with an overall experience of 22 ys both in Clinical as well as Teaching. She received her Master’s degree in Hospital Administration 2017 from Jaipur University, India. She joined Tawam in March 2009 as a RN in Oncology unit. She has extensive experience and skills with various divisions within oncological care. She did Research in Oncology unit about assessing fatigue and activity intolerance in patients with cancer receiving treatment. She was a conference speaker at the 6th SEHA international Nursing, Midwifery and Allied health conference last September 2017 Abu Dhabi. She presented in EIOC in 2019 , 9th EOC in 2021. She is also a committee member of the Nursing Midwifery education & Research Unit (NMERU) at Tawam Hospital and is completing a Quality Improvement Project aimed at standardizing central line care and management. Currently she is the Lead of Oncology Educational Nursing advisory Group. "

Mr. Mahmoud Abdul Rahim Hasan

Assistant Director of Nursing | United Arab Emirates

Mahmoud is the Assistant Director of Nursing for Oncology, Medical, Surgical, Al Wagan Hospital, and Regional Blood Bank at Tawam Hospital (UAE). He graduated from the Makkassed National College of Nursing, Lebanon in 2001 with a Bachelor of Sciences in Nursing and he completed his Master degree in Healthcare Management from the Royal College of Surgeons in Ireland in Dubai (RCSI-Dubai) in June 2010. He is an Oncology Certified Nurse by the Oncology Nursing Society (ONS, USA). Mahmoud chaired all the annual nursing sessions in the Emirates Oncology Conference from 2013 till today. He participated in a lot of activities to improve patient quality of care such as introducing the new appointment system in the oncology Clinic at Tawam Hospital (2010), introducing the new Medical Assessment & Planning Unit (MAPU) in 2017, End of life Outreach Nurse project (2017), Discharge project (2017-2018), Oncology Nurse Navigator program (2017) and Oncology Nurse Triage project (2018). He also work with oncology nursing team at Tawam hospital to conduct number of oncology nursing researches such as improving oral chemotherapy compliance in Oncology Clinic (2017), improving patient experience with Chemotherapy-induced nausea and vomiting (CINV), Tawam Experience (2017) and Assessing the Patient Education needs of Thalassemia Patients taking Iron chelating factors, Experience of Tawam hospital adult hematology/oncology department in the UAE (2018).

Mr. Mohammad Mah'D Saleh

Oncology Center Manager | United Arab Emirates

Mr. Saleh is an Oncology Certified Nurse OCN with extensive clinical experience in oncology/hematology. After vast years of experience in nursing from a clinical educator, Nurse Manager and now being the Tawam Oncology Center Manager. He participates effectively in training and developing nursing staff. Mohammad has served as a Chemotherapy and Biotherapy Trainer since 2011 and was the first international trainer at the level of UAE. He was responsible for a variety of quality improvement initiatives and hospital quality measures such as central line associated blood stream infections (CLABSI), prevention of chemotherapy error, and improving the safe handling of hazardous drugs, and management of radiation therapy side effects based in the latest evidence based practice. Mohammad, actively participates in oncology service development and collaborate with others in setting the standards in cancer care and improve quality and cancer patient’s outcome through continuum of care, and customer services and be connected with local and international cancer centers.

Dr. Jawaher Ali Ansari

Acting Chief, Oncology Clinic | United Arab Emirates

Dr Jawaher Ansari completed his Clinical Oncology specialist training in Birmingham, UK and worked as a Consultant at the Beatson Cancer Centre in Glasgow, the second largest cancer center in the UK, prior to moving to the Middle East. Dr Ansari has been a principal investigator for several international clinical trials and has authored several peer-reviewed publications and textbook chapters. He has a specialist interest in Urology, Breast and Lung cancers.

Dr. Mawada Hussein

Medical Oncologist | United Arab Emirates

Medical Oncologist in United Arab Emirates

Dr. Mohammad Hourani

Medical Oncologist | United Arab Emirates

Medical Oncologist at UAE

Dr. Shilpi Roy

Medical Oncologist | United Arab Emirates

Medical Oncologist at UAE

Dr. Khalid Saeed Balaraj

Chair of Oncology Service | United Arab Emirates

Dr. Khalid Balaraj was initially trained in the United Kingdom. He has radiation oncology qualifications from - UK (FRCR (I), Ireland (FFR RCSI) and Canada (FRCPC). He has done 2 Clinical Fellowships from Canada, in Gynecology Brachytherapy and CNS Stereotactic Radiotherapy. He has worked as an Assistant Professor in Al Faisal University, Riyadh, as well as Consultant of Radiation Oncology, for 7 years, treating patients on the latest technology, including IMRT, IGRT, Tomotherapy, Rapid Arc and Cyber- Knife at King Faisal specialist Hospital, Riyadh. Dr. Balaraj has treated patients on international RTOG trials. He has been General Secretary of the Saudi Cancer Society and Oncology Advisor for the CME Oncology Program Middle East. Joined Tawam hospital as a chairman of Radiation oncology department on September 2011 Currently he is an assistant professor at UAE University and the chairman of Tawam hospital Oncology Services and the chair of oncology service line at SEHA.

Prof. Hennie Botha

Professor and Head of Department of Obstetrics and Gynaecology | South Africa

Hennie Botha is Professor and Head of Department of Obstetrics and Gynaecology at Stellenbosch University of and Tygerberg Hospital in South Africa. He started his professional career in a rural hospital in Malawi. Returning to South Africa he specialised in Obstetrics and Gynaecology and then did further training in the field of Gynaecological Oncology in the United Kingdom. He has authored or co-authored many articles in journals and is co-editor of the textbook “Clinical Gynaecology”. His research focus is on cervical cancer prevention and treatment, including in people living with HIV. He collaborates with national and international researchers. He served on the council of the International Gynaecological Cancer Society and is International vice-chair of the HV Group of the AIDS malignancy consortium. Prof Botha is enthusiastic about under-and postgraduate teaching and training and his unit has trained many specialists and sub-specialists in South Africa and other African countries.

Prof. Hennie Botha

Professor and Head of Department of Obstetrics and Gynaecology | South Africa

Hennie Botha is Professor and Head of Department of Obstetrics and Gynaecology at Stellenbosch University of and Tygerberg Hospital in South Africa. He started his professional career in a rural hospital in Malawi. Returning to South Africa he specialised in Obstetrics and Gynaecology and then did further training in the field of Gynaecological Oncology in the United Kingdom. He has authored or co-authored many articles in journals and is co-editor of the textbook “Clinical Gynaecology”. His research focus is on cervical cancer prevention and treatment, including in people living with HIV. He collaborates with national and international researchers. He served on the council of the International Gynaecological Cancer Society and is International vice-chair of the HV Group of the AIDS malignancy consortium. Prof Botha is enthusiastic about under-and postgraduate teaching and training and his unit has trained many specialists and sub-specialists in South Africa and other African countries.

Dr. Saad Ghazal Aswad

Gynecological Oncologist | United Arab Emirates

"Dr. Aswad obtained his MD from Aleppo University, Syria in 1980. Subsequently, he did his post-graduate training in O&G in the UK and became a Member of the Royal College of Obstetricians and Gynecologist in 1988 and a Fellow in 2000. He pursued further subspecialty training in Gynecological Oncology (Gateshead, UK) and obtained his Ph.D. from the University of Newcastle Upon-Tyne, the UK in 1994. Prior to moving to the UAE, he was a Senior Consultant in the Northern Region of England and Lecturer at the University of Newcastle Upon-Tyne, UK. Over the last fifteen years, Dr. Aswad has been providing nationwide Gynecological Oncology Services in Tawam Hospital, UAE. In recognition of his significant contribution to maternal health issues in UAE, Dr. Aswad was awarded distinction Fellowship of the Faculty of Public Health of the Royal Colleges of Physicians of United Kingdom. Apart from the FFPH, he was awarded the Clinical Service Distinction Award (CMHS, UAEU), Best Department Award in UAE Hospitals (Sheikh Hamdan Bin Rashid Al-Maktoum Award for Medical Sciences), Outstanding Contribution to Medical Education in the Middle East (Arab Health) and many other UK national awards. Dr. Aswad has more than sixty full papers and abstracts published in National and International Medical Journal and Conference Proceedings, four book chapters and nine educational videos. Dr. Aswad is an active member of many National and International Scientific Societies."

Prof. Hennie Botha

Professor and Head of Department of Obstetrics and Gynaecology | South Africa

Hennie Botha is Professor and Head of Department of Obstetrics and Gynaecology at Stellenbosch University of and Tygerberg Hospital in South Africa. He started his professional career in a rural hospital in Malawi. Returning to South Africa he specialised in Obstetrics and Gynaecology and then did further training in the field of Gynaecological Oncology in the United Kingdom. He has authored or co-authored many articles in journals and is co-editor of the textbook “Clinical Gynaecology”. His research focus is on cervical cancer prevention and treatment, including in people living with HIV. He collaborates with national and international researchers. He served on the council of the International Gynaecological Cancer Society and is International vice-chair of the HV Group of the AIDS malignancy consortium. Prof Botha is enthusiastic about under-and postgraduate teaching and training and his unit has trained many specialists and sub-specialists in South Africa and other African countries.

Dr. Thikra A M Hassan

Chief of Oncology-Obs. And Gyno | United Arab Emirates

Chief of Oncology-Obs. And Gyno. – Tawam Hospital

Dr. Emad Dawoud

Consultant Physician, Oncology Clinic | United Arab Emirates

Dr. Emad Dawoud is a Consultant Medical Oncologist in Oncology department at Tawam hospital UAE, and Assistant professor of clinical oncology in Al Azhar University Cairo, Egypt. Dr. Dawoud has been principal investigator and co- investigator for more than 50 clinical trials and abstract published per reviewed journals and he is a member of various associations such as ASCO, ESMO, ESTRO.

Dr. Ikram Burney

Senior Consultant in Medical Oncology | Oman

"Dr. Ikram Burney is a Senior Consultant in Medical Oncology at Sultan Qaboos University Hospital (SQUH). He graduated from Pakistan and received his training in Medical Oncology at the Aga Khan University in Karachi, Hammersmith Hospital in London, and Southampton University Hospital. He has been working at SQUH since 2003 and his area of interest includes Lymphoproliferative disorders, Gynecological malignancies, Sarcoma and Melanoma, and Supportive care in Oncology. He has more than 90 publications in peer-reviewed journals."

Prof. Hennie Botha

Professor and Head of Department of Obstetrics and Gynaecology | South Africa

Hennie Botha is Professor and Head of Department of Obstetrics and Gynaecology at Stellenbosch University of and Tygerberg Hospital in South Africa. He started his professional career in a rural hospital in Malawi. Returning to South Africa he specialised in Obstetrics and Gynaecology and then did further training in the field of Gynaecological Oncology in the United Kingdom. He has authored or co-authored many articles in journals and is co-editor of the textbook “Clinical Gynaecology”. His research focus is on cervical cancer prevention and treatment, including in people living with HIV. He collaborates with national and international researchers. He served on the council of the International Gynaecological Cancer Society and is International vice-chair of the HV Group of the AIDS malignancy consortium. Prof Botha is enthusiastic about under-and postgraduate teaching and training and his unit has trained many specialists and sub-specialists in South Africa and other African countries.

Dr. Saad Ghazal Aswad

Gynecological Oncologist | United Arab Emirates

"Dr. Aswad obtained his MD from Aleppo University, Syria in 1980. Subsequently, he did his post-graduate training in O&G in the UK and became a Member of the Royal College of Obstetricians and Gynecologist in 1988 and a Fellow in 2000. He pursued further subspecialty training in Gynecological Oncology (Gateshead, UK) and obtained his Ph.D. from the University of Newcastle Upon-Tyne, the UK in 1994. Prior to moving to the UAE, he was a Senior Consultant in the Northern Region of England and Lecturer at the University of Newcastle Upon-Tyne, UK. Over the last fifteen years, Dr. Aswad has been providing nationwide Gynecological Oncology Services in Tawam Hospital, UAE. In recognition of his significant contribution to maternal health issues in UAE, Dr. Aswad was awarded distinction Fellowship of the Faculty of Public Health of the Royal Colleges of Physicians of United Kingdom. Apart from the FFPH, he was awarded the Clinical Service Distinction Award (CMHS, UAEU), Best Department Award in UAE Hospitals (Sheikh Hamdan Bin Rashid Al-Maktoum Award for Medical Sciences), Outstanding Contribution to Medical Education in the Middle East (Arab Health) and many other UK national awards. Dr. Aswad has more than sixty full papers and abstracts published in National and International Medical Journal and Conference Proceedings, four book chapters and nine educational videos. Dr. Aswad is an active member of many National and International Scientific Societies."

Dr. Thikra A M Hassan

Chief of Oncology-Obs. And Gyno | United Arab Emirates

Chief of Oncology-Obs. And Gyno. – Tawam Hospital

Dr. Emad Dawoud

Consultant Physician, Oncology Clinic | United Arab Emirates

Dr. Emad Dawoud is a Consultant Medical Oncologist in Oncology department at Tawam hospital UAE, and Assistant professor of clinical oncology in Al Azhar University Cairo, Egypt. Dr. Dawoud has been principal investigator and co- investigator for more than 50 clinical trials and abstract published per reviewed journals and he is a member of various associations such as ASCO, ESMO, ESTRO.

Dr. Stephanie Ricci

Consultant Gynecologic Oncologist | United Arab Emirates

"Stephanie Ricci, MD is an Assistant professor of OB GYN at the Lerner College of Medicine at the Cleveland Clinic and a Consultant Gynecologic Oncologist in the Oncology Institute at Cleveland Clinic Abu Dhabi. Prior to joining Cleveland Clinic Abu Dhabi, Dr. Ricci was an Assistant professor of OB GYN in the division of Gynecologic Oncology at the Cleveland Clinic. Dr. Ricci received her medical degree from the University of Connecticut School of Medicine in the USA, where she also completed her residency in Obstetrics and Gynecology. Following residency, Dr. Ricci completed a Fellowship in Gynecologic Oncology at Johns Hopkins Hospital, USA. Throughout her tenure, Dr. Ricci has specialized in gynecologic oncology completing over 3000 operations from minimally invasive surgery to cytoreductive surgeries with heated intraperitoneal chemotherapy. Her research interests have focused mainly on clinical patient care including rare uterine tumors, time to treatment and survivorship in women with gynecologic cancer. During her last six years at Cleveland Clinic in Ohio she served as the Gyn lead for the uterine transplant program which is the largest deceased donor program in the world. "

Dr. Hassan Jaafar

Medical Oncology Consultant | United Arab Emirates

Dr. Hassan Jaafar is a consultant medical oncologist with more than 25 years of professional experience. He commenced his career in Internal Medicine in 1994 and ultimately qualified in oncology/hematology in the year 2000 from the American University of Beirut Medical Centre. Later that year, Dr. Jaafar relocated to the UAE and joined Tawam Hospital, a 500+ bed, tertiary-care hospital, affiliated with the reputed Johns Hopkins University Hospital in the USA. During that time, he served as an adjunct Assistant Professor of Internal Medicine at the College of Medicine and Health – UAEU. He later relocated to Sheikh Khalifa Specialty Hospital (SKSH) operated by Seoul National University Hospital (SNUH) in Ras-Al-Khaimah. With his arrival at BCI as a Consultant Medical Oncologist, Dr. Jaafar moves up yet another notch in his career to be rated as one of the frontline oncologists and cancer research specialists in the UAE region. Major areas of clinical and research interest include breast cancer and gynecological cancers, lung cancer, colorectal cancer, sarcomas, and other solid tumors. Dr. Jaafar worked on multiple publications in esteemed journals and has a plethora of abstracts and cases presented at conferences around the world. Below is a brief sample of his publications.

Dr. Ikram Burney

Senior Consultant in Medical Oncology | Oman

"Dr. Ikram Burney is a Senior Consultant in Medical Oncology at Sultan Qaboos University Hospital (SQUH). He graduated from Pakistan and received his training in Medical Oncology at the Aga Khan University in Karachi, Hammersmith Hospital in London, and Southampton University Hospital. He has been working at SQUH since 2003 and his area of interest includes Lymphoproliferative disorders, Gynecological malignancies, Sarcoma and Melanoma, and Supportive care in Oncology. He has more than 90 publications in peer-reviewed journals."

Dr. Fathi Azribi

Consultant Medical Oncologist | United Arab Emirates

Dr Fathi Azribi is a Consultant Medical Oncologist. He graduated from Tripoli University, Libya, then completed specialty training in Oncology in the UK and obtained a Certificate of Completion of Training in Medical Oncology. His main interest is in thoracic, breast, gynaecological and gastrointestinal malignancies, with expertise in treatment with chemotherapy, immunotherapy, hormonal, and targeted therapy. He published several papers and abstracts in peer reviewed journals. He also founded the first Medical Oncology Fellowship program in the UAE.

Dr. Stephanie Ricci

Consultant Gynecologic Oncologist | United Arab Emirates

"Stephanie Ricci, MD is an Assistant professor of OB GYN at the Lerner College of Medicine at the Cleveland Clinic and a Consultant Gynecologic Oncologist in the Oncology Institute at Cleveland Clinic Abu Dhabi. Prior to joining Cleveland Clinic Abu Dhabi, Dr. Ricci was an Assistant professor of OB GYN in the division of Gynecologic Oncology at the Cleveland Clinic. Dr. Ricci received her medical degree from the University of Connecticut School of Medicine in the USA, where she also completed her residency in Obstetrics and Gynecology. Following residency, Dr. Ricci completed a Fellowship in Gynecologic Oncology at Johns Hopkins Hospital, USA. Throughout her tenure, Dr. Ricci has specialized in gynecologic oncology completing over 3000 operations from minimally invasive surgery to cytoreductive surgeries with heated intraperitoneal chemotherapy. Her research interests have focused mainly on clinical patient care including rare uterine tumors, time to treatment and survivorship in women with gynecologic cancer. During her last six years at Cleveland Clinic in Ohio she served as the Gyn lead for the uterine transplant program which is the largest deceased donor program in the world. "

Dr. Hassan Jaafar

Medical Oncology Consultant | United Arab Emirates

Dr. Hassan Jaafar is a consultant medical oncologist with more than 25 years of professional experience. He commenced his career in Internal Medicine in 1994 and ultimately qualified in oncology/hematology in the year 2000 from the American University of Beirut Medical Centre. Later that year, Dr. Jaafar relocated to the UAE and joined Tawam Hospital, a 500+ bed, tertiary-care hospital, affiliated with the reputed Johns Hopkins University Hospital in the USA. During that time, he served as an adjunct Assistant Professor of Internal Medicine at the College of Medicine and Health – UAEU. He later relocated to Sheikh Khalifa Specialty Hospital (SKSH) operated by Seoul National University Hospital (SNUH) in Ras-Al-Khaimah. With his arrival at BCI as a Consultant Medical Oncologist, Dr. Jaafar moves up yet another notch in his career to be rated as one of the frontline oncologists and cancer research specialists in the UAE region. Major areas of clinical and research interest include breast cancer and gynecological cancers, lung cancer, colorectal cancer, sarcomas, and other solid tumors. Dr. Jaafar worked on multiple publications in esteemed journals and has a plethora of abstracts and cases presented at conferences around the world. Below is a brief sample of his publications.

Dr. Ikram Burney

Senior Consultant in Medical Oncology | Oman

"Dr. Ikram Burney is a Senior Consultant in Medical Oncology at Sultan Qaboos University Hospital (SQUH). He graduated from Pakistan and received his training in Medical Oncology at the Aga Khan University in Karachi, Hammersmith Hospital in London, and Southampton University Hospital. He has been working at SQUH since 2003 and his area of interest includes Lymphoproliferative disorders, Gynecological malignancies, Sarcoma and Melanoma, and Supportive care in Oncology. He has more than 90 publications in peer-reviewed journals."

Dr. Thikra A M Hassan

Chief of Oncology-Obs. And Gyno | United Arab Emirates

Chief of Oncology-Obs. And Gyno. – Tawam Hospital

Dr. Zuhdi Khalid

Consultant, Gyn oncology | United Arab Emirates

Consultant, Gyn oncology, Latifa Hospital

Dr. Emad Dawoud

Consultant Physician, Oncology Clinic | United Arab Emirates

Dr. Emad Dawoud is a Consultant Medical Oncologist in Oncology department at Tawam hospital UAE, and Assistant professor of clinical oncology in Al Azhar University Cairo, Egypt. Dr. Dawoud has been principal investigator and co- investigator for more than 50 clinical trials and abstract published per reviewed journals and he is a member of various associations such as ASCO, ESMO, ESTRO.

Dr. Emad Dawoud

Consultant Physician, Oncology Clinic | United Arab Emirates

Dr. Emad Dawoud is a Consultant Medical Oncologist in Oncology department at Tawam hospital UAE, and Assistant professor of clinical oncology in Al Azhar University Cairo, Egypt. Dr. Dawoud has been principal investigator and co- investigator for more than 50 clinical trials and abstract published per reviewed journals and he is a member of various associations such as ASCO, ESMO, ESTRO.

Dr. Fathi Azribi

Consultant Medical Oncologist | United Arab Emirates

Dr Fathi Azribi is a Consultant Medical Oncologist. He graduated from Tripoli University, Libya, then completed specialty training in Oncology in the UK and obtained a Certificate of Completion of Training in Medical Oncology. His main interest is in thoracic, breast, gynaecological and gastrointestinal malignancies, with expertise in treatment with chemotherapy, immunotherapy, hormonal, and targeted therapy. He published several papers and abstracts in peer reviewed journals. He also founded the first Medical Oncology Fellowship program in the UAE.

Dr. Hassan Jaafar

Medical Oncology Consultant | United Arab Emirates

Dr. Hassan Jaafar is a consultant medical oncologist with more than 25 years of professional experience. He commenced his career in Internal Medicine in 1994 and ultimately qualified in oncology/hematology in the year 2000 from the American University of Beirut Medical Centre. Later that year, Dr. Jaafar relocated to the UAE and joined Tawam Hospital, a 500+ bed, tertiary-care hospital, affiliated with the reputed Johns Hopkins University Hospital in the USA. During that time, he served as an adjunct Assistant Professor of Internal Medicine at the College of Medicine and Health – UAEU. He later relocated to Sheikh Khalifa Specialty Hospital (SKSH) operated by Seoul National University Hospital (SNUH) in Ras-Al-Khaimah. With his arrival at BCI as a Consultant Medical Oncologist, Dr. Jaafar moves up yet another notch in his career to be rated as one of the frontline oncologists and cancer research specialists in the UAE region. Major areas of clinical and research interest include breast cancer and gynecological cancers, lung cancer, colorectal cancer, sarcomas, and other solid tumors. Dr. Jaafar worked on multiple publications in esteemed journals and has a plethora of abstracts and cases presented at conferences around the world. Below is a brief sample of his publications.

Dr. Dina Hamza

Consultant Medical Oncologist | United Arab Emirates

Consultant medical oncology Completed training in Oncology 2001 National Cancer Institute - Masters degree in clinical Oncology Cairo University - Fellowship from ULM university Germany - European Board certified from European school of Oncology worked in different health care systems Working in Dubai since 2008 Had more than 20 publications in oncology the most citation was for the MENA Breast Guidelines; acknowledged by e-cancer search foundation Member of the most dynamic, scientific and leading organization; EOS

Dr. Fathi Azribi

Consultant Medical Oncologist | United Arab Emirates

Dr Fathi Azribi is a Consultant Medical Oncologist. He graduated from Tripoli University, Libya, then completed specialty training in Oncology in the UK and obtained a Certificate of Completion of Training in Medical Oncology. His main interest is in thoracic, breast, gynaecological and gastrointestinal malignancies, with expertise in treatment with chemotherapy, immunotherapy, hormonal, and targeted therapy. He published several papers and abstracts in peer reviewed journals. He also founded the first Medical Oncology Fellowship program in the UAE.

Dr. Ikram Burney

Senior Consultant in Medical Oncology | Oman

"Dr. Ikram Burney is a Senior Consultant in Medical Oncology at Sultan Qaboos University Hospital (SQUH). He graduated from Pakistan and received his training in Medical Oncology at the Aga Khan University in Karachi, Hammersmith Hospital in London, and Southampton University Hospital. He has been working at SQUH since 2003 and his area of interest includes Lymphoproliferative disorders, Gynecological malignancies, Sarcoma and Melanoma, and Supportive care in Oncology. He has more than 90 publications in peer-reviewed journals."

Dr. Emad Dawoud

Consultant Physician, Oncology Clinic | United Arab Emirates

Dr. Emad Dawoud is a Consultant Medical Oncologist in Oncology department at Tawam hospital UAE, and Assistant professor of clinical oncology in Al Azhar University Cairo, Egypt. Dr. Dawoud has been principal investigator and co- investigator for more than 50 clinical trials and abstract published per reviewed journals and he is a member of various associations such as ASCO, ESMO, ESTRO.

Prof. Rami Mahfouz

Tenured Professor and Head of Division of Clinical Pathology | Lebanon

"Earned his medical degree from the American University of Beirut followed by a Clinical Pathology residency and a Fellowship in Molecular Pathology at St Jude Children’s Research Hospital in Memphis, Tennessee focusing on HLA and molecular diagnostics and microarrays technology in research. In 2002, he joined the Department of Pathology and Laboratory Medicine at the American University of Beirut Medical Center as Assistant Professor and worked since then on establishing a Molecular Diagnostics Laboratory with a service scope covering different specialties including Transplantation, Molecular Microbiology, and Molecular Pathology. His major research interests include Natural killer cell immunoglobulin-like receptors (KIR) genotyping, HLA associations, and cancer profiling. He has 198 publications and serves as Associate and Executive editor on several international journals including GENE and META GENE. He is currently a Tenured Professor and Head of Division of Clinical Pathology in the Department of Pathology and Laboratory Medicine at AUBMC and the Director of the Histocompatibility and Molecular Diagnostics Laboratory, Director of the Residency Training Program, and Chairman of the Biomedical Institutional Review Board. He is a member of several international and professional societies including the College of American Pathologists (CAP), the American Society of Histocompatibility and Immunogenetics (ASHI), and the American Association of Molecular Pathologists (AMP) where he is serving as the Chairman of its International Affairs Committee."

Dr. Lina Wahba

Clinical Pharmacy Lead | United Arab Emirates

Dr. Lina Wahba is a clinical pharmacy lead and she also works as an adjunct lecturer at the Faculty of Medicine and Health Sciences, United Arab Emirates University. She earned her BSc in Pharmacy from the Faculty of Pharmacy, Jordan University of Science and Technology-Jordan, then had her MSc degree in Clinical Pharmacy from UCL, school of pharmacy/UK. She conducted her clinical training at Barts’ and the London NHS hospital trust-London. Lina is board certified oncology pharmacist. She maintains a primary clinical practice in Tawam oncology unit, and leading the Medication use evaluation committees. Lina has been having a major role in optimizing patient care in addition to creating and updating the oncology protocols. During her career, Lina worked as a clinical pharmacist in different institutions. She established the clinical pharmacy services in the paediatric oncology ward at King Hussein cancer centre- Amman/Jordan. She has many publications in addition to different abstracts that had been presented in the UK clinical pharmacy association conference, the American Society of Health System Pharmacists association (ASHP), Emirates Oncology Conference, and in the Journal of Oncology Pharmacy Practice (JOPP). Finally, Lina is the principal pharmacist in a number of Phase III multinational RCTs which are involving investigational chemotherapeutic and targeted agents.

Dr. Taif Sarraj

Chief of Clinical Support Services | United Arab Emirates

"Taif S. Al Sarraj, Ph.D., M.Sc., RD., is the Chief of Clinical Support Services for three major hospitals (Tawam, AlAin, and AlWagan hospitals) within the AlAin Region of the Emirate of Abu-Dhabi. Previously served as Deputy COO at Shaikh Khalifa Medical City (SKMC), and as an Adjunct Assistant Professor at the UAE University’s Faculty of Medicine and Health Sciences. Dr Taif Al Sarraj has 25 years of extensive experience in healthcare leadership, operation, and performance management. In addition to quality and patient safety, JCI accreditation, and disasters' incident commanding. On the other hand, she has experience in clinical researches, academic education, continues clinical education, national and international conferences organization and participation, health education and public health awareness and contribution through community out-reach activities, awareness lectures, and media interviews via national media programs. Dr Al Sarraj is a Fellow Candidate of the American College of Healthcare Executives (ACHE). She had successfully led and manage the clinical support services as well as hospital operation activities throughout her leadership and rotation experience across SEHA hospitals. She participated in COVID-19 pandemic's disaster management, commissioning of MBZ field hospitals, and AD Covid-19 designated hospital. Dr Al Sarraj is the recipient of The Abu Dhabi Medical Distinguish Award (Department of Health - 2011); The SEHA Nursing & Allied Health leadership Award (SEHA in 2013); The Emirates Women Award (Dubai Quality Group in 2012), The UAE Rare Diseases Society Excellence Award (UAE Genetic Diseases Association 2017); The Shaikh Rashid Award for Academic Superiority (The UAE Culture & Scientific Association, twice in 2011 and 1997); Dr. Robert G. Jensen Award for Excellent Research in Nutritional Sciences (University of Connecticut 2009). In 2020, Dr. AlSarraj was awarded the Distinguished Alumni Award by the University of Connecticut, College of AHNR, for her distinguished contributions to the Healthcare sector in UAE. Dr. AlSarraj excelled in clinical nutrition. Her research interests are in the area of pathophysiology of metabolic syndrome, and diabetes complications, glucose and lipid metabolism, inflammation markers and vascular complications. Voluntary Activities: -Ambassador of Abu-Dhabi Public Health Center -Chair of Medical Unit within the Al Ain Group- for the preparation of FIFA U-17 World Cup (17th Oct- 8th Nov 2013 United Arab Emirates)"

Ms. Iman Al Ameri

Psychologist | United Arab Emirates

Iman Hashem Al Ameri has been working as a psychologist in Tawam Hospital Oncology Centre since 2012. She received the Bachelor degree in psychology in 2009 from the United Arab Emirates University and her Post Graduation Professional Clinical Diploma in Applied Psychological Skills and Competencies in Mental Health in 2014 from the College of Medicine at the United Arab Emirates University in Al Ain.

Ms. Sumeya Al Hammadi

Manager of Rehabilitation Services | United Arab Emirates

Ms Sumeya Mohammed Al Hammadi , manager at Al Ain Region Rehabilitation Department has extensive 17 years professional experience in the field of Rehabilitation . Graduated from University of Sharjah in 2006 , Sumeya is practicing as an expert physiotherapist dealing with different clinical conditions. She is an expert Lymphedema therapist, certified & trained in Germany, Foeldi Clinic. Ms Sumeya is a speaker, a researcher and a successful leader in Alain region.

Ms. Salwa Al Saedi

Speech and Language Pathologist | United Arab Emirates

Salwa is a speech and language pathologist working under SEHA Al Ain region. Salwa completed her bachelor degree in general linguistics in 2008 at UAE University. In 2012, Salwa gained her first master degree in Applied Linguistic form the University of Sydney, Australia. Two years later, Salwa completed her second master degree in Speech and language pathology at the same university. Post master degree completion, Salwa resumed working at Tawam Hospital providing both inpatient and outpatient services, and taking part in HAAD and SEHA SLP committee. At the moment, Salwa is working as a supervisor SLP across two facilities (Tawam and Al Ain hospital) providing acute care services and outpatient services with main focus in head and neck oncology.

Ms. Theresa Binz

Manager of Radiation Therapy | United Arab Emirates

Theresa Binz Qualified in 1999 as radiation therapist at the Cape Peninsula University of Technology (CPUT) in Cape Town, South Africa. Soon after, she worked 2 years in Germany followed by 2 years in The Netherlands, where she furthered her studies in radiotherapy. After returning back to South Africa, she completed both the BTech and Master’s degree at CPUT, achieving, Suma Cum Laude for her Master’s degree. In South Africa she worked for 10 years at a Groote Schuur Hospital where she specialised in radiation therapy planning. She has been on a variety of expert missions as representatives of the IAEA, to provide clinical skills training, lectures and site evaluations. She has been part of the development of the Access to Care program in Cape Town (varian skills training platform), and a part time lecturer at CPUT. Currently she is the manager of Radiotherapy at Tawam Hospital in Al Ain, Abu Dhabi, United Arab Emirates.

Mr. Amjad Hussain

Radiation Oncology Medical Physicist | United Arab Emirates

"Dr. Amjad Hussain is a Radiation Oncology Medical Physicist at Tawam Hospital, Al Ain since July 2022. He is also a certified Radiation Safety Officer (RSO). He received his Masters in Medical Physics from Pakistan Institute of Engineering and Applied Sciences, Islamabad, in 2003. In 2011 he graduated with a CAMPEP accredited Ph.D. degree from the University of Calgary, AB, Canada. Before joining Tawam, Dr. Hussain worked as a Senior Medical Physicist at CancerCare Manitoba, Canada Sr. Medical Physicist and Assistant Professor at the Aga Khan University Hospital (AKUH) in Pakistan. He did his post-doctoral fellowship from University of Calgary, AB. Dr. Hussain is a full member of the American Association of Physicists in Medicine (AAPM, since 2015) and a full member of the Canadian College of Physicists in Medicine (MCCPM, since 2016). He is the author of 23 scientific papers and 29 abstracts, published in reputable international journals. "

Dr. Noura Aldhaheri

Assistant Professor at the Department of Pediatrics | United Arab Emirates

Noura AlDhaheri is an Assistant Professor at the Department of Pediatrics, College of Medicine and Health Sciences (CMHS), UAE University. Dr. AlDhaheri holds American Board of Pediatrics certification and is qualified in Medical Genetics & Genomics and Medical Biochemical Genetics. Dr. AlDhaheri obtained her pediatric residency training at Children’s National Medical Center in Washington DC, USA (2012-2015) then training in Medical Genetics from Johns Hopkins School of Medicine and National Institute of Health in the United States (2015-2017). Following that, she completed Medical Biochemical Genetics Fellowship at Baylor College of Medicine and Texas Children Hospital in Houston, TX, USA in November 2018 and joined CMHS- UAE University as an Assistant Professor. She is also a consultant Clinical Genetics and Medical Biochemical Genetics at Tawam Hospital, Al Ain. Dr. AlDhaheri’s current research focus is in Genomic Medicine. Specifically, rare disease and identification of novel genes for rare disease in several cohorts including: cleft lip/palate, VACTERL/VATER and vertebral malformation cohorts in an attempt to help “solve” Mendelian disorders for which the genetic etiology is presently unknown.